Biogen Inc. buy BMO Capital Markets
Start price
08.08.23
/
50%
€249.40
Target price
08.08.24
€306.84
Performance (%)
-25.40%
End price
09.08.24
€186.05
Summary
This prediction ended on 09.08.24 with a price of €186.05. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.40%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -1.327% | -1.327% | 2.330% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $347.00 to $336.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten